The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ORIC PHARMACEUTICALS INC COM 68622P109 14,756 602,272 SH   SOLE   602,272 0 0
ROYALTY PHARMA PLC SHS CL A G7709Q104 116,930 2,680,644 SH   SOLE   2,680,644 0 0
VANECK VECTORS ETF TR GOLD MINERS ETF 92189F106 24,001 738,500 SH   SOLE   738,500 0 0
Y-MABS THERAPEUTICS INC COM 984241109 6,560 216,916 SH   SOLE   216,916 0 0